Back
KBC Groupe NV Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
39
KBCSY
KBC Groupe NV
Last Price:
35.20
Seasonality Move:
2.9%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
33.07
Seasonality Move:
6.63%
Sell
39
KBC Groupe NV (KBCSY)
is a Sell
Is KBC Groupe NV a Buy, Sell or Hold?
- The current KBC Groupe NV [KBCSY] share price is $35.68. The Score for KBCSY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- KBCSY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $33.15. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KBCSY Stock Price Chart
What is KBC Groupe NV's stock price today?
-
The KBC Groupe NV share price today is $35.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBCSY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $33.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
KBCSY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 47.83 | Sell |
Chaikin Money Flow: | 22292 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.13 - 36.73) | Sell |
Bollinger Bands (100): | (34.48 - 37.86) | Sell |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.01 | Buy |
Relative Strength Index (14 RSI): | 64.44 | Buy |
Chaikin Money Flow: | -648557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.98 - 30.18) | Buy |
Bollinger Bands (100): | (24.4 - 28.72) | Buy |
KBCSY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.34 | Buy |
20-day SMA: | 35.68 | Sell |
50-day SMA: | 36.68 | Sell |
200-day SMA: | 33.29 | Buy |
8-day EMA: | 35.55 | Buy |
20-day EMA: | 35.78 | Sell |
50-day EMA: | 36.19 | Sell |
200-day EMA: | 34.68 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.76 | Buy |
20-day SMA: | 27.49 | Buy |
50-day SMA: | 25.93 | Buy |
200-day SMA: | 28.17 | Buy |
8-day EMA: | 31.17 | Buy |
20-day EMA: | 28.66 | Buy |
50-day EMA: | 27.01 | Buy |
200-day EMA: | 27 | Buy |
KBC Groupe NV Earnings Growth & KBCSY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
KBC Groupe NV Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |